This website uses cookies to enhance the user experience.
||
H

HALEON NORWAY AS914 596 947

Purchase and sale
Limited company
3. etasje Lysaker torg 5 1366 LYSAKER, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

HALEON NORWAY AS

Operating
Import, markedsføring, fremme, distribusjon og salg av medisiner over disk (OTC), andre legemidler, medisinsk utstyr, kosmetikk, næringsmidler, kosttilskudd, kjemikalier og dagligvareartikler, engrossalg av OTC og legemidler samt forretningsaktivitet i tilknytning til dette. Selskapet kan også engasjere seg i all slags forretningsvirksomhet med andre selskaper eller inneha aksjer i selskaper for å utøve slik virksomhet.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
SB

Signe Beate Kullmann1981

Chairman of the board
SB

Signe Beate Kullmann1981

Years since formation
12 years
since Dec 10, 2014
Type
Limited company
VAT registered
Yes
Number of employees
19

Ownership

Number of shares and share classes
1,000
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
557,119,995
NOK
Annual total result 2024
11,808,819
NOK
Total equity 2024
49,524,245
NOK
Last update: Dec 12, 2025

Management

Management / administration

NameRoleShares
SB

Signe Beate Kullmann

1981

Managing Director/CEO-

Board

NameRoleShares
SB

Signe Beate Kullmann

1981

Chairman-
GV

Georgii Vysots'ki

1994

Board Member-

Others

NameRoleShares
K
KPMG AS
Auditor-
A
AMESTO ACCOUNTHOUSE AS
Accountant-
Last update: Apr 24, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
HU

Haleon Uk Services Limited

Ordinary shares
1,000
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
557,119,995
521,266,385
468,470,297
430,122,237
Annual Total Result
11,808,819
10,773,703
10,489,944
6,554,008
Total assets
158,295,817
170,669,549
156,493,720
116,626,572
Total liabilities
108,771,572
132,954,124
113,351,998
83,974,794
Total equity
49,524,245
37,715,425
43,141,722
32,651,778

P&L

Year2024202320222021
Total operating income
557,119,995
521,266,385
468,470,297
430,122,237
Total operating costs
544,543,244
509,679,831
455,802,434
421,432,582
Operating result
12,576,751
11,586,554
12,667,863
8,689,655
Financial income/costs
2,590,081
2,255,294
807,618
37,420
Profit before tax
15,166,832
13,841,848
13,475,481
8,727,075
Total tax & extraordinary income/cost
3,358,013
3,068,145
2,985,537
2,173,067
Annual Total Result
11,808,819
10,773,703
10,489,944
6,554,008

Balance overview

Year2024202320222021
Total fixed assets
1,543,814
2,032,565
2,026,541
2,603,161
Total current assets
156,752,003
168,636,984
154,467,179
114,023,411
Total assets
158,295,817
170,669,549
156,493,720
116,626,572
Short term debt
108,365,168
132,771,867
113,329,097
83,974,794
Long term debt
406,404
182,257
22,901
0
Total liabilities
108,771,572
132,954,124
113,351,998
83,974,794
Contributed capital
20,961,006
20,961,006
20,961,006
20,961,006
Retained earnings
28,563,239
16,754,419
22,180,716
11,690,772
Total equity
49,524,245
37,715,425
43,141,722
32,651,778
Total equity and liabilities
158,295,817
170,669,549
156,493,720
116,626,572

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods